NCCN Global
International Adaptations & Translations of the NCCN Clinical Practice Guidelines
in Oncology (NCCN Guidelines®):
Adaptations
The NCCN adaptations account for metabolic differences in populations, accessibility of technology, and regulatory status of health care technologies used in cancer management in the specified country.
The NCCN Guidelines: Local Editions are developed by the host country's oncology thought leaders in conjunction with NCCN Guidelines Panel Members. Modified NCCN Guidelines are developed to aid clinicians in determining appropriate and effective avenues of care in the specified country. Learn more about the adaptation process.
Asia Consensus Statements
European Editions: Spain
Latin America Editions
Middle East & North Africa (MENA) Editions
Updates coming soon
Translations
Requests for translations of NCCN Content continue to increase with multiple countries seeking NCCN Guidelines resources in their native languages. As a result, NCCN works to translate the NCCN Guidelines into multiple languages and publishes these important resources on NCCN.org as well as within NCCN mobile applications for free access by clinicians around the world.
Chinese Translations
Croatian Translation
Czech Translation
French Translations
French Canadian Translations
German Translations
Italian Translations
Japanese Translations
NCCN has consented to direct non-adapted translations of the Complete Library of NCCN Guidelines® into Japanese by a major, national university in Kyoto, Japan. Please visit the Translational Research Informatics Center’s website for additional information.
Polish Translations
Portuguese Translations
Russian Translations
South Korean Translations
Spanish Translations
Turkish Translations
Distress Thermometer Screening Tool Translations
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Arabic)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Bahasa Indonesia)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Bengali)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Chinese)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (French)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (German)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Greek)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Hebrew)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Hindi)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Italian)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Japanese)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2017 (Norwegian)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Korean)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Polish)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Portuguese)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Russian)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Spanish)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Romanian)
- Distress Thermometer Screening Tool Figure (DIS-A), V.2.2020 (Swedish)
NCCN International Adaptations and Translations from before 2012 are available upon request.
Disclaimer
Translated versions of the NCCN Guidelines are coordinated by NCCN and with legal
permission from NCCN. The NCCN Guidelines are a statement of evidence and consensus
of the authors regarding their views of currently accepted approaches to treatment.
Any clinician seeking to apply or consult these guidelines is expected to use independent
medical judgment in the context of individual clinical circumstances to determine
any patient’s care or treatment. The National Comprehensive Cancer Network
makes no representations or warranties of any kind regarding their content, use
or application and disclaims any responsibility for their application or use in
any way. The NCCN Guidelines are copyrighted by National Comprehensive Cancer Network.
All rights reserved. The NCCN Guidelines and the illustrations herein may not be
reproduced in any form without the express written permission of NCCN.
© 2018 National Comprehensive Cancer Network, Inc. All rights reserved. The
NCCN Guidelines® and illustrations herein may not be reproduced in
any form for any purpose without the express written permission of the NCCN. To
view the most recent and complete version of the NCCN Guidelines, go online to NCCN.org. NATIONAL
COMPREHENSIVE CANCER NETWORK®, NCCN®, NCCN GUIDELINES®, and
all other NCCN Content are trademarks owned by the National Comprehensive Cancer
Network, Inc.
NCCN Guidelines: International Derivatives
NCCN Guidelines®: Local Editions – Country-specific
clinical practice guidelines in English or the local language(s). They include adaptations
accounting for metabolic differences in populations, accessibility of technology,
and regulatory status of health care technologies used in cancer management in the
specified country. The NCCN Guidelines: Local Editions are developed by the host
country's oncology thought leaders in conjunction with NCCN Guidelines Panel Members.
Modified NCCN Guidelines are developed to aid clinicians in determining appropriate
and effective avenues of care in the specified country.
NCCN Guidelines®: Consensus Statements – Manuscript
statements outlining, describing, and rationalizing variations in care within a
country or region or across multiple countries within a region as compared to the
recommendations of the NCCN Guidelines. An exploratory and analytical account of
the impact of genetic variations in metabolism of agents, regulatory environments,
and practice standards of participating countries.
About the NCCN Guidelines: Local Editions Adaption Process
NCCN authorizes selected groups to adapt the NCCN Guidelines® to
reflect genetic variations in metabolism of agents and regulatory environments of
host countries, subject to approval by NCCN and representatives of NCCN's disease-specific
panels.
Participating countries select disease-specific representatives to review and suggest
modifications to specific NCCN Guidelines®. It is important that
the fields of surgical oncology, medical oncology, and radiation oncology are represented
for each type of cancer. Representatives are recognized experts in the management
of these malignancies in their home countries. In addition, because the process
involves the development of consensus through compromise, they are sufficiently
influential that they can speak for the general oncology community in their own
countries.
Members of each committee receive a copy of the most recent version of the NCCN
Guidelines for the specific type of cancer. The members circulate the NCCN
Guidelines among a representative group of multidisciplinary physicians in their
country to determine areas where local practice is not concordant with the NCCN
Guidelines. There is discussion of how the NCCN Guidelines might be adapted to accommodate
local circumstances. The representative to the regional meeting is responsible for
bringing these recommendations forward to the regional meeting.
A regional meeting is conducted so that all participating representatives can develop
a single proposal for adaptation of the disease-specific NCCN Guidelines. Any proposed
modification of the NCCN Guidelines must be supported by data.
At this meeting, NCCN Guidelines Panel Members present the data used to develop
the NCCN Guidelines and representatives of the regional alliance present proposed
changes and the literature that supports them. A discussion of the issues takes
place and at the end of the meeting, a consensus is developed regarding an adaptation
of the NCCN Guidelines that is acceptable to the NCCN. Any changes from the
original NCCN Guidelines are identified in the adaptations.
Opportunities for Collaboration and Sponsorship
We welcome the opportunity to explore potential
business collaborations with you.
For general NCCN queries and domestic programs, please visit our main
Contact Page.